Orphan Medical Will Launch Sucraid For Sucrase Deficiency In June

Orphan Medical will launch Sucraid (sacrosidase) for treatment of the genetic disorder CSID in early June.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet